Spago Nanomedical AB (publ)
SPAGO
Rank in Stocks
#31122
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Share Price
$0.00448359
Last synced: 2026-11-13
Market Cap
$3.58M
Change (1 day)
-1.11%
Change (1 year)
-61.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Spago Nanomedical AB (publ) (SPAGO)
Category
Healthcare
EPS for Spago Nanomedical AB (publ) (SPAGO)
EPS as of September 2026 TTM: $0.00
According to Spago Nanomedical AB (publ)'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for Spago Nanomedical AB (publ) from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -60.00% |
| 2025 | $-0.01 | -23.00% |
| 2024 | $-0.01 | -51.92% |
| 2023 | $-0.02 | -25.18% |
| 2022 | $-0.03 | -45.28% |
| 2021 | $-0.05 | 31.27% |
| 2020 | $-0.04 | -19.71% |
| 2019 | $-0.05 | 72.14% |
| 2018 | $-0.03 | -50.79% |
| 2017 | $-0.06 | 21.58% |
| 2016 | $-0.05 | -21.87% |
| 2015 | $-0.06 | -22.11% |
| 2014 | $-0.08 | -22.64% |
| 2013 | $-0.10 | -82.08% |
| 2012 | $-0.55 | 150.59% |
| 2011 | $-0.22 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 22,150.00% |
US
|
|
| $15.66 | -391,600.00% |
US
|
|
| $-7.07 | 176,650.00% |
US
|
|
| $-5.29 | 132,150.00% |
AU
|
|
| $12.73 | -318,405.00% |
BE
|
Questions about Spago Nanomedical AB (publ)'s earnings per share (EPS)
What is Spago Nanomedical AB (publ)'s earnings per share (EPS)?
Spago Nanomedical AB (publ)'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2026.
What was Spago Nanomedical AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Spago Nanomedical AB (publ)'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has Spago Nanomedical AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Spago Nanomedical AB (publ)'s earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2021 ($-0.05).
How does Spago Nanomedical AB (publ)'s earnings per share (EPS) compare with similar companies?
Spago Nanomedical AB (publ)'s earnings per share (EPS) ($0.00) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.